Press release
Immunotherapy Drugs Market Trends, Key Players Analysis, Regional Trends, Competitive Landscape, and Industry Potential by 2028
Merck & Co., Inc. stands out as a leader in the immunotherapy sector, showcasing a robust pipeline of advanced immunotherapeutic drugs through the utilization of cutting-edge biotechnologies. The company's expertise spans therapeutic areas including onco
The global immunotherapy drugs market [https://www.marketsandmarkets.com/Market-Reports/immunotherapy-drug-market-137717755.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is expected to grow from USD 285.3 billion in 2024 to USD 580.6 billion by 2029, at a CAGR of 15.3% This growth is fuelled by advancements in antibody engineering, increasing demand for antibody therapies in cancer treatment, and a rising preference for personalized and targeted medicines. Immunotherapy drugs work by enhancing or modulating the immune system to effectively target and eliminate disease-causing agents. Despite these promising prospects, the market faces challenges such as the complex and costly development of antibody therapeutics and stringent regulatory approval processes. Opportunities include increased collaborations among pharmaceutical companies, CROs, and academic institutions, which drive innovation and expedite drug development. Key segments include antibody drugs and cancer treatments, with intravenous administration being the fastest-growing route. North America is expected to dominate the market, supported by extensive research, high cancer prevalence, and growing adoption of immunotherapy. Key players in the market include Merck & Co., Inc., Johnson & Johnson Services, Inc., F. Hoffman-La Roche Ltd., Pfizer Inc., AstraZeneca, Novartis AG, Amgen Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Sanofi, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., GSK PLC, and Abbvie Inc.
Download PDF Brochure: [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137717755&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Browse in-depth TOC on "Immunotherapy Drugs Market"
341 - Tables
53 - Figures
348 - Pages
MERCK & CO., INC. (US): Innovator in Immunotherapy
Merck & Co., Inc. stands out as a leader in the immunotherapy sector, showcasing a robust pipeline of advanced immunotherapeutic drugs through the utilization of cutting-edge biotechnologies. The company's expertise spans therapeutic areas including oncology, immunology, and infectious diseases, supported by a strong commitment to research excellence and strategic collaborations. Merck's focus on immunotherapy is evident in its targeted acquisitions and partnerships, such as those with AstraZeneca plc (UK) and Eisai Co., Ltd. (Japan) for cancer immunotherapy. Notable innovations include KEYTRUDA, a groundbreaking drug for cancer treatment, highlighting Merck's dedication to developing impactful therapies and advancing therapeutic innovation.
JOHNSON & JOHNSON SERVICES, INC. (US): Comprehensive Immunotherapy Solutions
Johnson & Johnson Services, Inc. is a prominent player in the immunotherapy drugs market, offering a diverse portfolio of approved therapies across multiple therapeutic areas, including oncology, immunology, and infectious diseases. The company's extensive geographical presence and well-established global distribution network are key strengths, enabling it to address a wide range of medical needs effectively. Johnson & Johnson's strategy emphasizes a diversified immunotherapy portfolio, rigorous quality standards, and strategic partnerships to enhance research and market access. This approach reduces reliance on any single drug and supports the development of innovative therapies to meet diverse patient needs.
F. HOFFMANN-LA ROCHE LTD. (Switzerland): Pioneer in Immunotherapy Innovations
F. Hoffmann-La Roche Ltd is a leading force in the immunotherapy drugs market, providing an extensive range of products for hospitals and specialty care centers. The company boasts several approved immunotherapy drugs and a strong global distribution presence. Roche's strengths include pioneering innovative therapies, rigorous quality control, and deep disease biology insights, which contribute to developing transformative treatments and improving patient outcomes. Noteworthy recent developments include the launch of the IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and the ATRX Rabbit Polyclonal Antibody in February 2023, designed to identify mutation statuses in brain cancer patients.
Request Sample Pages: [https://www.marketsandmarkets.com/requestsampleNew.asp?id=137717755&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Type Segmentation: Antibody Drugs Dominate
The immunotherapy drugs market is segmented into antibody drugs, inhibitor drugs, interferons & interleukins, cancer vaccines, and other immunotherapy drugs, including oncolytic virus therapy and T-cell therapy. In 2023, antibody drugs held the largest market share, driven by rising cancer rates, increased adoption of biological therapies, growing R&D investments, and supportive government policies. This segment's dominance is expected to continue, bolstered by ongoing advancements in therapeutic development and increased focus on personalized medicine.
Application Segmentation: Cancer Leads the Market
The immunotherapy drugs market is categorized by applications into cancer, autoimmune & inflammatory diseases, hematology, osteology, neurology, and other areas such as ophthalmology, dermatology, and cardiovascular diseases. In 2023, cancer emerged as the leading application area, capturing the largest market share. This is attributed to the growing prevalence of cancer, increasing R&D spending, and the expanding array of approved immunotherapy treatments specifically designed to address various cancer types.
Route of Administration Segmentation: Intravenous Route is Key
The market is segmented by route of administration into intravenous, subcutaneous, and other routes (intravitreal and intramuscular). In 2023, the intravenous route accounted for the largest market share and is expected to grow at the highest CAGR during the forecast period. This growth is driven by the intravenous route's ability to deliver drugs directly into the bloodstream, ensuring rapid and consistent therapeutic effects, particularly for conditions like cancer and autoimmune diseases.
End User Segmentation: Hospitals Lead
Based on end users, the immunotherapy drugs market is divided into hospitals, long-term care facilities, and other specialty care centers. In 2023, hospitals commanded the largest share of the market. Hospitals extensively utilize monoclonal antibodies (mAbs) for their targeted therapy capabilities, rapid diagnostic applications, and effectiveness in treating various diseases, including cancer, autoimmune disorders, and infectious diseases.
Regional Insights: North America Holds the Largest Share
The immunotherapy drugs market is segmented into six regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2023, North America held the largest market share, followed by Europe and the Asia Pacific. The growth in North America is driven by robust immunotherapy research, an expanding healthcare sector, increasing cancer prevalence, and the rising approval and adoption of immunotherapy drugs for treating chronic diseases.
For more information, inquire now! [https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=137717755&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]
Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=immunotherapy-drugs-market-trends-key-players-analysis-regional-trends-competitive-landscape-and-industry-potential-by-2028]
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/immunotherapy-drug-market-137717755.html
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunotherapy Drugs Market Trends, Key Players Analysis, Regional Trends, Competitive Landscape, and Industry Potential by 2028 here
News-ID: 3720317 • Views: …
More Releases from ABNewswire
Rhino Rescue's Quality Pledge: Unveiling the Extreme Resilience of Core Componen …
Discover Rhino Rescue's quality pledge through our extreme component testing. See why our tactical gear is built to perform.
Our Commitment and Responsibility
In the life and death arena of emergency response, where seconds matter, the dependability of your equipment is absolute. It is a fact that has been guiding our mission since our parent company, Nanchi Medical, was established in 2010. Having a 14-year history in the first aid industry and…
Tampa SEO Launches Cutting-Edge Local Search Optimization Services to Help Tampa …
Tampa SEO, a full-service digital marketing agency based in Tampa Bay, today announced the official launch of its enhanced SEO and digital marketing services at http://tampa-seo.net. The company specializes in helping local businesses increase their online visibility, generate qualified leads, and outperform competitors through data-driven, ethical search engine optimization strategies.
Helping Local Businesses Thrive in the Digital Age
With nearly 97% of consumers searching online for local services before making a purchase,…
Fibromyalgia Market Expected to Gain Momentum Through 2034, According to DelveIn …
The Key Fibromyalgia Companies in the market include - Tonix Pharmaceutical, UCB Biopharma SRL, GlaxoSmithKline, UCB Pharma, Pierre Fabre Medicament, UCB Pharma, Eli Lilly and Company, Merck, Aptinyx, Astellas Pharma, AstraZeneca, RiboCor, Inc., Bial - Portela C S.A, and others.
DelveInsight's "Fibromyalgia Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Fibromyalgia, historical and forecasted epidemiology as well as the Fibromyalgia market trends in the United States,…
DMB Plumbing & Heating Urges Homeowners to Schedule Pre-Winter Heating Inspectio …
DMB Plumbing & Heating Inc. of Bridgewater, led by Dean Blanchard, is urging homeowners to schedule pre-winter heating inspections.
As temperatures in Massachusetts begin to dip and residents prepare their homes for another New England winter, DMB Plumbing & Heating Inc., a locally owned and operated company based in Bridgewater, is reminding homeowners of the importance of pre-winter heating inspections.
Founded and operated by Dean Blanchard, DMB Plumbing & Heating has long…
More Releases for Merck
Swine Fever Vaccine Market Detailed in New Research Report By 2032 | Merck & Co. …
🚀 𝐒𝐰𝐢𝐧𝐞 𝐅𝐞𝐯𝐞𝐫 𝐕𝐚𝐜𝐜𝐢𝐧𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐭𝐨 𝐠𝐫𝐨𝐰 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟓.𝟗% (𝟐𝟎𝟐𝟓 - 𝟐𝟎𝟑𝟐)
The Swine Fever Vaccine Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
» 70% efforts of Primary Research
» 15% efforts of Secondary Research
» 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited companies
📈…
Women's Health Market Industry Growth Report to 2031 Merck KGaA, Merck & Co, Fer …
[New York, December 2024] Women's Health encompasses a broad spectrum of medical and wellness services tailored to address the unique health needs of women across all life stages. This crucial sub-market of healthcare highlights the necessity for specialized treatments, preventive care, and holistic wellness approaches that resonate with today's female patients. Women's Health isn't just a niche sector; it represents a burgeoning field within healthcare, mirrored by an increasing global…
Laboratory Syringe Market Size, Growing Demand to 2036 GESERCO, Merck Millipore, …
A laboratory syringe is a precise instrument commonly used for the accurate measurement and transfer of liquids or gases in scientific experiments. Unlike standard medical syringes, laboratory syringes are often made of materials such as glass or high-quality plastic to withstand chemical reactions and offer greater clarity for observing contents. They come in a range of sizes, from as small as 1 mL to over 100 mL, and are often…
Leuprorelin Acetate Market Analysis By Top Keyplayers - Merck, Takeda, MediGene, …
The "Leuprorelin Acetate Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Leuprorelin Acetate Market, 2024-2031
Verified Market Research's most recent report, "Leuprorelin Acetate Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth…
Avelumab Market Analysis By Top Key Players - Merck, Pfizer, Merck
The "Avelumab Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Avelumab Market, 2024-2031
Verified Market Research's most recent report, "Avelumab Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the…
Nanobodies Market to See Booming Growth 2021-2028 | Novo Nordisk A/S, Merck & Co …
𝐍𝐚𝐧𝐨𝐛𝐨𝐝𝐢𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 top level players are analyzed in report based on current and future development status, and Nanobodies market estimations from 2021 to 2028 in terms of revenue and volume. This report provides strategic recommendations consulted by the industrial experts including market share worldwide, future outlook, cost profit structure, supply, raw materials, labour cost, manufacturing expenses, latest market trends, demands, ROI.
The Nanobodies market report analyse the manufacturing cost of the…
